期刊文献+

白芍总苷对胶原性关节炎滑膜组织中Bcl-2、Bax表达的影响 被引量:22

Effect of total glucosides of paeony on Bbcl-2,Bax expression in rats of synovial tissue with collagen-induced arthritis
下载PDF
导出
摘要 目的研究白芍总苷(TGP)对胶原性关节炎滑膜组织中Bcl2、Bax表达的影响。方法SD大鼠随机分成4组,正常组、模型组和TGP大、小剂量组;采用鸡Ⅱ型胶原皮内注射诱导大鼠胶原性关节炎(CIA)模型;运用免疫组织化学法检测各组滑膜组织Bcl2、Bax蛋白的表达。结果正常SD大鼠滑膜组织Bcl2和Bax均有表达,模型组Bcl2、Bax表达明显高于正常组,但Bcl2/Bax比例比正常组高;TGP(25、50mg/kg)治疗组可明显下调Bcl2蛋白的表达,上调Bax蛋白表达,Bcl2/Bax比例下降,与模型组比较,差异有显著性(P<0.01)。结论Bcl2、Bax参与CIA的发病过程,TGP可下调滑膜组织中Bcl2表达、上调Bax表达及降低Bcl2/Bax的比值,这可能是其治疗CIA的机制之一。 Objective To investigate the effect of total glucosides of paeony(TGP)on Bcl-2, Bax expression in rats of synovial tissue with collagen-induced arthritis(CIA). Methods SD rats were divided randomly into four groups including normal, model, TGP(25, 50 mg/kg) groups. Chicken type Ⅱ collagen-induced arthritis model was established in rats. The expression of Bcl-2, Bax on synovial tissue were detected by means of immunohistochemistry. Results The expression of Bcl-2, Bax was higher in model group than that of the normal group. And compared with the model group , the expression of Bcl-2 protein was decreased, Bax protein was increased and the ratio of Bcl-2/Bax was decreased in TGP groups. Conclusion Bcl-2 and Bax protein play a role in the development of CIA. TGP can decrease the expression of Bcl-2 and increase the Bax protein ,then decrease the ratio of Bcl-2/Bax, which may be one of the mechanism of TGP improvement CIA.
出处 《安徽医科大学学报》 CAS 北大核心 2006年第2期143-146,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金资助项目(编号:No30271606) 安徽省自然科学基金资助项目(编号:00044411)
关键词 白芍 滑膜/病理学 radix paeoniae alba synovial membrane/pathology
  • 相关文献

参考文献11

  • 1Chen Q,Wei W.Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats[J].Int Immunopharmacol,2003,3 (4):593-608.
  • 2王志坚,陈敏珠,孙桂华,徐叔云.白芍总甙治疗类风湿性关节炎的临床药理研究[J].中国药理学通报,1994,10(2):117-122. 被引量:81
  • 3Tebib J G.Apoptosis:relevance to rheumatology.Rer Rheum Engl ED,1995,62(10):618 -26.
  • 4孙妩弋,张玲玲,吴丽,汪倪萍,王华,岳莉,张运芳,魏伟.重组人白细胞介素-1受体拮抗剂对大鼠胶原性关节炎的治疗作用[J].中国药理学通报,2005,21(1):92-95. 被引量:9
  • 5Firestein G S,Yeo M,Zvaifler N J.Apoptosis in rheumatoid arthritis synovium[J].J Clin Invest,1995,96 (3):1631-8.
  • 6Hilbers I,Hansen T,Petrow P K,et al.Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium.Rheumatol Int,2003,23 (2):75-81.
  • 7Wakisaka S,Suzuki N,Takeba Y,et al.Modulation by proinflammtory cytikines of Fas/Fas ligand-mediated apoptotoic cell death of synovial cells in patients with rheumatoid arthritis (RA)[J].Clin Exp Immunol,1998,114 (1):119-28.
  • 8Kawakami A,Eguchi K,Matsuoka N,et al.Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1[J].Arthritis Rheum,1996,39(8):1267 -76.
  • 9Sugiyama M,Tsukazaki T,Yoneckura A,et al.Location of apoptosis and related proteins in the synovium of patients with rheumatoid arthritis[J].Ann Rheum Dis,1996,55(7):442 -9.
  • 10Kurowska M,Rudnicka W,Kontny E,et al.Fivroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15receptor complex:endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-Xl and Bcl-2[J].J Immunol,2002,169 (4):1760-7.

二级参考文献13

  • 1李文敬 见:李文敬 孙希志 曹导源 苏厚恒主编.类风湿病[M].见:李文敬,孙希志,曹导源,苏厚恒主编.实用风湿病学 第2版[C].济南:山东科学技术出版社,2001.235-54.
  • 2Taylor PC. Anti-eytokines and cytokines in the treatment of rheumatoid arthritis[J]. Curt Pharm Des, 2003,9(14) : 1095 - 106.
  • 3Hallegua DS, Weisman MH. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases[ J]. Ann Rheum Dis,2002, 61(11) : 960-7.
  • 4Freeman BD, Buchman TG.Interleukin-I receptor antagonist as therapy for inflammatory disorders [ J ]. Expert Opin Biol Ther,2001, 1(2) : 301 -8.
  • 5Rubbert-Roth A, Perniok A. Treatment of patients with rheumatoid arthritis with the interleukin-I receptor antagonist anakinra(Kineret) [J]. Z Rheumatol, 2003, 62(4) :367 -77.
  • 6Chen Q, Wei W. Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats[ J ]. Int Immunopharmacol, 2003, 3(4) : 593 -608.
  • 7Fjuisawa H, Nishimara T, Motohaga A. Effect of actart on type Ⅱ collagen induced arthritis in mice [ J]. Arznein Forsh/Drug Res,1994, 44( l): 64-76.
  • 8Chowdhary RK, Ratkay LG, Neyndorff HC et al. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice [ J ]. Clin Immunol Immunopathol, 1994,72(2) :255 -63.
  • 9Park SH, Min D J, Cho ML et al. Shift toward T helper 1 cytokines by type Ⅱ collagen-reactive T cells in patients with rheumatoid' arthritis[J]. Arthritis Rheum, 2001,44(3) :561 -9.
  • 10Arend WP. The balance between IL-I and IL-IRa in disease[J].Cytokine Growth Factor Rev, 2002, 13(4-5) : 323 -40.

共引文献88

同被引文献303

引证文献22

二级引证文献462

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部